Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human chromatin is a highly organized complex of DNA and proteins, primarily histones, that packages the genome within the cell nucleus (NHGRI, 2024). It serves as the physiological template for all genetic processes, including transcription, replication, and repair, by alternating between condensed (heterochromatin) and relaxed (euchromatin) states (Nature Education, 2014). Dysregulation of chromatin structure and the epigenetic marks that govern it is a fundamental driver of various diseases, particularly cancer, where it leads to the silencing of tumor suppressor genes or the activation of oncogenes (Nature Reviews Cancer, 2016). Therapeutic strategies involve small molecules that inhibit enzymes responsible for modifying histones or DNA, as well as agents that bind directly to the DNA-protein complex to disrupt cellular proliferation (Clinical Epigenetics, 2021). Understanding chromatin dynamics is essential for developing precision medicines that can selectively reset the epigenetic landscape of diseased cells (Nature Reviews Drug Discovery, 2018).
Drugs target chromatin through several mechanisms: epigenetic modulation via inhibition of "writers", "erasers", or "readers" (e.g., HDAC and DNMT inhibitors); direct DNA intercalation to disrupt topoisomerase activity; and covalent DNA cross-linking to prevent strand separation (Nature Reviews Drug Discovery, 2018; PubMed, 2019).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human chromatin.